Sophie Papa

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study

Leticia Monin, Adam G. Laing, Miguel Muñoz‐Ruiz et al. · The Lancet Oncology · 2021 · 612 citations · Full text

Veterinary Medicine, Immunology, Oncology +14

Design of a Phase I Clinical Trial to Evaluate Intratumoral Delivery of ErbB-Targeted Chimeric Antigen Receptor T-Cells in Locally Advanced or Recurrent Head and Neck Cancer

May CI van Schalkwyk, Sophie Papa, Jean‐Pierre Jeannon et al. · Human Gene Therapy Clinical Development · 2013 · 123 citations

Medicine, Immunology, Oncology +17

Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients

Sultan Abdul-Jawad, Luca Baù, Thanussuyah Alaguthurai et al. · Cancer Cell · 2021 · 117 citations · Full text

Life Sciences, Immunology, Oncology +14

Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non–Small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors

Adam J. Schoenfeld, Sylvia M. Lee, Bernard Doger de Spéville et al. · Cancer Discovery · 2024 · 108 citations · Full text

Life Sciences, Immunology, Oncology +17

Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: A 10-year experience

Loı̈c Lang-Lazdunski, Andrea Billè, Sophie Papa et al. · Journal of Thoracic and Cardiovascular Surgery · 2014 · 94 citations · Full text

Medicine, Oncology, Surgery +14